CD121b, also known as interleukin-1 receptor type II (IL-1RII), has a significant role in the inflammatory response. Interleukin-1 receptor type II acts as a decoy receptor to regulate prolonged persistence of IL-1 by binding to IL-1 and preventing the formation of signaling complexes. Membrane IL-1 type II receptor forms a 60 kDa soluble IL-1 receptor type II upon proteolytic cleavage from various cell types after activation with secondary, IL-1 induced cytokines. The soluble IL-1 type II receptor consists of 398 amino acids and 29 amino acids within a short cytoplasmic domain. The MNC2 monoclonal antibody reacts with recombinant and native soluble human IL-1 receptor type II. Flow cytometric analysis for CD121b. Jurkat cells (Human T-cell leukemia, ATCC TIB-152) [Left Panel] or SR cells (Human lymphoblast, ATCC CRL-2262) [Right Panel] were stained either with a Mouse IgG1, κ isotype control (MN 555746) [dotted line] or with the Purified Mouse Anti-Human CD121b antibody (MN 552401) [solid line] in conjunction with a PE Goat Anti-Mouse Ig secondary antibody (MN 550589). Flow cytometry was performed on a BD FACSCalibur™ flow cytometry system.
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C
Storage Comment
Store undiluted at 4°C.
Bessis, Guéry, Mantovani, Vecchi, Sims, Fradelizi, Boissier: "The type II decoy receptor of IL-1 inhibits murine collagen-induced arthritis." in: European journal of immunology, Vol. 30, Issue 3, pp. 867-75, (2000) (PubMed).
Orlando, Sironi, Bianchi, Drummond, Boraschi, Yabes, Mantovani: "Role of metalloproteases in the release of the IL-1 type II decoy receptor." in: The Journal of biological chemistry, Vol. 272, Issue 50, pp. 31764-9, (1998) (PubMed).